Study: Children With Alopecia Areata Respond to Tofacitinib
The chart review summarized the results in 11 pediatric patients, ages 8 to 18 years, all with a diagnosis of alopecia areata, who were treated with tofacitinib.
Medscape Medical News
source https://www.medscape.com/viewarticle/968410?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/968410?src=rss
Comments
Post a Comment